I'll give a short version of vaccine 101 here.
When the flu virus emerges, a new vaccine has to be made. It is a little more complicated, in that it is a different virus from the standard annual virus. There's an approval process that has to be gone through by the regulator.
In general, using egg-based technology, it takes about 20 to 22 weeks from the time they get the virus to the time they can start releasing the vaccine. That's just egg-based technology. You can shorten that by maybe four weeks using a cell culture-based technology. If we were to use some of the newer DNA technologies, we might be able to cut it in half. Canada was actually the first country in the world to develop a domestic capacity to produce a vaccine for its pandemic needs.
That isn't all the vaccine we need in one week; we have to wait until the vaccine is available. The capacity we had in the initial contract at the time was about eight million doses a month. That was put in place around 2000-01. The production capacity was upped so we might have the capacity to take on about 12 million doses a month, but it wasn't 30 million doses a month. We didn't have enough vaccine for all Canadians within a month after the pandemic. We also had that lag period.
Recognizing that even in a situation where we had earlier production of vaccines, the first wave had already passed before vaccine was available. We didn't start vaccinating until the second wave was approaching its peak. There were delays. There was demand. There was also the need for the infrastructure to be able to give the vaccine.
With regard to the provinces and territories, the agreement is that it's divided up based on population. The only exceptions to that were the three territories. Because the volume was so small, Yukon, the Northwest Territories, and Nunavut got all their vaccine at once. They didn't have the same prioritization concerns that the rest of the jurisdictions had based on the number of doses they were getting. They had it all. They just had to prioritize based on their ability to give vaccine using whatever mechanisms they used.
In terms of a geographic prioritization, by the time the vaccine was available, the virus was everywhere. If we'd had vaccine available earlier, perhaps one could have shifted...particularly if one could have intervened in the first wave, which was very spotty across the country. By the time the second wave happened in the fall, it literally was everywhere.